Photo by by Tony Rinaldo

Senior advisor to the science program, Academic Ventures at the Radcliffe Institute, professor of neurobiology at Harvard Medical School, and member of the Department of Pediatric Oncology at the Dana-Farber Cancer Institute

Rosalind A. Segal is senior advisor to the science program at the Radcliffe Institute and a professor of neurobiology at Harvard Medical School. She is also a member of the Department of Pediatric Oncology at the Dana-Farber Cancer Institute. She was part of the last class admitted to Radcliffe College and graduated from Harvard-Radcliffe in 1979 with a BA in biochemistry, summa cum laude. She received a PhD in cell biology from Rockefeller University and an MD from Weill Medical College of Cornell University. She was certified by the American Board of Psychiatry and Neurology in 1992. She joined the Harvard Medical School faculty in 1995, first in neurology, and then in neurobiology (1999). She was promoted to professor in 2006.

Her laboratory research focuses on the biology of brain tumors by probing the complex molecular machinery of the developing brain. The research aims to understand the mechanisms critical for normal development and how deregulated cellular proliferation, migration, and survival can cause brain tumors and other neurological diseases. Her honors include the Robert H. Ebert Clinical Professor award from the Esther A. and Joseph Klingenstein Fund, an award from the Claudia Adams Barr Program in Innovative Basic Cancer Research, and a NIH Directors Pioneer Award.